Skip to Content

Pyrazinamide Pregnancy and Breastfeeding Warnings

Medically reviewed on February 1, 2018.

Pyrazinamide Pregnancy Warnings

Pyrazinamide has been assigned to pregnancy category C by the FDA. There are no controlled data in human pregnancy. Pyrazinamide is only recommended during pregnancy when benefit outweighs risk.

See references

Pyrazinamide Breastfeeding Warnings

Pyrazinamide is excreted into human milk in small amounts. The manufacturer recommends that caution be used when administering pyrazinamide to nursing women.

See references

References for pregnancy information

  1. "Product Information. Pyrazinamide (pyrazinamide)." VersaPharm Inc, Marietta, GA.
  2. American Thoracic Society, CDC, Infectious Diseases Society of America "Treatment of tuberculosis." MMWR Morb Mortal Wkly Rep 52(RR-11) (2003): 1-77

References for breastfeeding information

  1. Holdiness MR "Antituberculosis drugs and breast-feeding." Arch Intern Med 144 (1984): 1888
  2. "Product Information. Pyrazinamide (pyrazinamide)." VersaPharm Inc, Marietta, GA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide